Specifically, in ovarian cancer cells resistant to platinum treatment, overexpressed CSN5 maintains CRT O-GlcNAc at a heightened level by destabilizing OGA, which stimulates a cytoprotective UPR to prevent the platinum-resistant EOC cells from chemotherapeutic killing (Figure 7O). This evidence concerns the gene CALR and ovarian carcinoma.